Search for: "Epstein Becker Green" Results 161 - 180 of 1,453
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jan 2023, 7:40 am by Amy K. Dow
The state laws at issue require that Mifepristone be taken in the presence of a physician, who must first provide state-mandated counseling to the patient before waiting 72 hours before administering the medication.[9] For additional resources on these topics, please see Epstein Becker Green’s From Roe to Dobbs additional resources [read post]
26 Jan 2023, 8:26 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Kate Heffernan, Marylana Helou, and Megan Robertson discuss how the changing state laws and regulations post-Dobbs may impact clinical research in different ways for different stakeholders [read post]
12 Jan 2023, 8:50 am by Epstein Becker Green
Epstein Becker Green attorneys Ted Kennedy, Jr.; Alexis Boaz; and Philo Hall discuss the current landscape of health care policy from both the legislative and regulatory perspectives and analyze which key health care issues may arise [read post]
10 Jan 2023, 8:39 am by Alaap B. Shah
Epstein Becker Green will be closely following the rulemaking process in these states as implementing regulations are developed, and as other states continue to legislate in this area. [read post]
23 Dec 2022, 11:29 am by Adam S. Forman and Nathaniel M. Glasser
Epstein, Becker & Green, P.C. will continue to monitor and publish updates on this topic. [read post]
1 Dec 2022, 8:49 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements [read post]
17 Nov 2022, 8:24 am by Epstein Becker Green
Brett and Epstein Becker Green construction attorney Chris Dunn analyze recent national trends in construction claims and discuss what health care owners can expect moving forward. [read post]
15 Nov 2022, 7:30 am by Amy Lerman
Since 2016, Epstein Becker Green has researched, compiled, and analyzed state-specific content relating to the regulatory requirements for professional mental/behavioral health practitioners and stakeholders seeking to provide telehealth-focused services. [read post]
3 Nov 2022, 8:50 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Jenny Nelson Carney, Stuart Gerson, Erin Sutton, and Dan Fahey discuss the post-Dobbs legislative landscape as well as the ongoing enforcement actions in the states that prohibit all or most abortions and abortion-related services. [read post]
2 Nov 2022, 1:39 pm by Shannon K. DeBra
For an additional summary of details regarding REHs, see the CMS Fact Sheet published on November 1, 2022 or for questions contact your Epstein Becker & Green, P.C. attorney. [read post]
2 Nov 2022, 8:51 am by Erik W. Weibust
Attorneys in Epstein Becker Green’s Trade Secret & Employee Mobility, White Collar Defense and Internal Investigations, and Antitrust practice groups are well equipped to advise companies, train employees, and provide representation in civil or criminal investigations and litigation involving alleged no poach agreements. [read post]
27 Oct 2022, 8:46 am by Epstein Becker Green
Epstein Becker Green is proud to sponsor the American Intellectual Property Law Association’s (AIPLA) 2022 Trade Secret Summit in Miami, FL on December 8-9, 2022. [read post]
Conclusion Epstein Becker & Green, P.C. will continue to monitor developments regarding the AEDT Law and will post an update when the DCWP issues final rules. [read post]
7 Sep 2022, 10:26 am by Epstein Becker Green
Thomson Reuters Practical Law has released the 2022 update to “Trade Secret Laws: Illinois,” a Q&A guide to state law on trade secrets and confidentiality for private employers, authored by our colleagues Peter Steinmeyer and David Clark at Epstein Becker Green. [read post]